EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ethical Considerations for Enrolling “Invested Parties” in Large‐Scale Clinical Studies: Insights from the RECOVER Initiative

Kellie Owens, Emily E Anderson, Shari Esquenazi-Karonika, Keith Hanson, Maika Mitchell, Janelle Linton, Jasmine Briscoe, Leah Castro Baucom, Liza Fisher, Rebecca Letts, Kian Nguyen, Brendan Parent

Ethics & Human Research · 2024

DOI: 10.1002/eahr.500221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ethics & Human Research, 2024. Verfasst von Kellie Owens und 11 weiteren Autor:innen. Beteiligte Einrichtung: Assistant professor in the division of medical ethics in the Department of Population Health at the New York University Grossman School of Medicine. Hauptthemen laut MEDLINE: COVID-19, Informed Consent. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health Agreement OTA, NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research institutions often lack policies addressing the risks and benefits of enrolling “invested parties” such as investigators, research staff, and patient, caregiver, and community representatives (groups most affected by a disease or intervention) in studies where they have direct involvement. Invested parties may have both strong motivations to study the condition or intervention and to participate as study subjects. More guidance is needed to promote appropriate access to research participation and mitigate potential risks. This article addresses the gap in guidance by presenting an ethical framework and practical guidelines for the enrollment of invested parties. Drawing from experiences with the Researching COVID to Enhance Recovery (RECOVER) Initiative, a large multisite observational cohort study, we argue that invested parties should not be categorically excluded from enrollment in their own research studies if certain criteria are met and appropriate safeguards are in place. We underscore the need to balance inclusion with fairness, promote valid voluntary informed consent, ensure data privacy, protect scientific validity, and mitigate unique risks to invested parties as participants. Additionally, we recommend regular reporting and empirical assessment to evaluate the impact of enrolling invested parties on participants and study outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Informed ConsentHumansResearch SubjectsResearch PersonnelPatient SelectionCohort StudiesEthics, ResearchBiomedical Research

Stichwörter der Autor:innen

conflicts of interesthuman subjects researchinformed consentprivacyresearch ethicsself‐experimentationstudy recruitment

Autor:innen und Institutionen

  • Assistant professor in the division of medical ethics in the Department of Population Health at the New York University Grossman School of Medicine.
  • Professor of bioethics at the Stritch School of Medicine at the Neiswanger Institute for Bioethics & Health Policy at Loyola University of Chicago.
  • Senior program director in the Department of Integrative Health at the New York University Grossman School of Medicine.
  • Pediatric hospitalist at the University of Illinois College of Medicine at Peoria and the Order of Saint Francis Healthcare Children's Hospital of Illinois.
  • Senior director of RECOVER Clinical Science Core Administration & Operations of the New York University Grossman School of Medicine.
  • Assistant program director in the Department of Population Health at the New York University Grossman School of Medicine.

Förderung

  • National Institutes of Health Agreement OTA
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Owens, K., Anderson, E. E., Esquenazi-Karonika, S., Hanson, K., Mitchell, M., Linton, J., Briscoe, J., Baucom, L. C., Fisher, L., Letts, R., Nguyen, K., & Parent, B. (2024). Ethical Considerations for Enrolling “Invested Parties” in Large‐Scale Clinical Studies: Insights from the RECOVER Initiative. Ethics & Human Research. https://doi.org/10.1002/eahr.500221

Vancouver

Owens K, Anderson EE, Esquenazi-Karonika S, Hanson K, Mitchell M, Linton J, et al. Ethical Considerations for Enrolling “Invested Parties” in Large‐Scale Clinical Studies: Insights from the RECOVER Initiative. Ethics & Human Research. 2024. doi:10.1002/eahr.500221

BibTeX
@article{Owens2024,
  author = {Owens, Kellie and Anderson, Emily E and Esquenazi-Karonika, Shari and Hanson, Keith and Mitchell, Maika and Linton, Janelle and Briscoe, Jasmine and Baucom, Leah Castro and Fisher, Liza and Letts, Rebecca and Nguyen, Kian and Parent, Brendan},
  title = {Ethical Considerations for Enrolling “Invested Parties” in Large‐Scale Clinical Studies: Insights from the RECOVER Initiative},
  journal = {Ethics & Human Research},
  year = {2024},
  doi = {10.1002/eahr.500221}
}
Kostenlos starten →